文献速递头颈外科

N2b期偏侧扁桃体癌同侧颈部放疗——需谨慎对待

Ipsilateral neck radiotherapy in N2b well-lateralized tonsil cancer - Approach with caution.
PubMed 文献 · Head Neck · 2019-05-06

单中心回顾性系列纳入2004至2011年接受同侧颈部放疗的偏侧扁桃体癌患者53例,对侧颈部复发率7.5%(4/53),4例均为p16阳性T1N2bM0;N2b亚组(28/53)对侧颈部复发率14.3%。随后改为N2b患者双侧颈部IMRT,23例中未观察到对侧颈部复发。

要点

  • N2b偏侧扁桃体癌同侧颈部放疗后对侧颈部复发率14.3%(4/28)。
  • 4例对侧颈部复发均为p16阳性、T1、N2b、M0肿瘤。
  • N2b患者改用双侧颈部IMRT后23例中未观察到对侧颈部复发。

核心结论

  • 在N2b人群中观察到高于预期的对侧颈部复发率,对这些患者采用双侧颈部IMRT是安全的替代方案。

研究设计与样本

  • 单中心回顾性系列,纳入2004至2011年间接受同侧颈部放疗的偏侧扁桃体癌患者53例。
  • 随后分析23例接受双侧颈部调强放疗(IMRT)的N2b患者结局。

主要发现

  • 53例接受同侧颈部放疗的患者中对侧颈部复发率为7.5%(4/53)。
  • 4例对侧颈部复发患者均为p16阳性、T1、N2b、M0肿瘤。
  • N2b亚组(28/53)对侧颈部复发率为14.3%。
  • 23例N2b患者接受双侧颈部IMRT后未观察到对侧颈部复发。

临床怎么用

  • 作者观察到N2b人群对侧颈部复发率高于预期,认为对N2b患者采用双侧颈部IMRT是安全的替代方案。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Treatment of the uninvolved neck in well-lateralized tonsillar squamous cell carcinoma is controversial. We became concerned after a number of contralateral neck recurrences (CNRs) in patients receiving ipsilateral radiotherapy (RT). METHODS: This is a single center retrospective series including patients with well-lateralized tonsillar cancer treated with ipsilateral neck RT between 2004 and 2011. RESULTS: We identified 53 patients treated with ipsilateral neck RT during the study period. The rate of CNR was 7.5% (4 of 53). All four patients had p16-positive, T1, N2b, M0 tumors. The subgroup of patients with N2b disease (28 of 53) had a CNR of 14.3%. We subsequently switched to treat patients with N2b with bilateral neck RT. We analyzed the outcomes of 23 patients with N2b treated with bilateral neck intensity-modulated RT (IMRT) and observed no CNRs. CONCLUSIONS: We observed a higher than expected rate of CNR in the N2b population. Bilateral neck IMRT for these patients represents a safe alternative.

来源:Head Neck,查看原文。版权归原作者所有。

引用

  1. Maskell D, Buckley H, Sission K, et al. Ipsilateral neck radiotherapy in N2b well-lateralized tonsil cancer - Approach with caution. Head Neck. 2019. PMID: 31059180. doi:10.1002/hed.25776

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。